BCK Partners’s Eli Lilly LLY Stock Holding History

BCK Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Buy	+200	New	+$204K	0.12%	25
2026 Q1	–	Sell	-214	Closed	-$230K	–	27
2025 Q4	$230K	Buy	+214	New	+$205K	0.12%	25
2025 Q2	–	Sell	-244	Closed	-$202K	–	28
2025 Q1	$202K	Buy	+244	New	+$203K	0.13%	25
2024 Q4	–	Sell	-284	Closed	-$252K	–	29
2024 Q3	$252K	Hold	284	–	–	0.12%	28
2024 Q2	$257K	Buy	+284	New	+$227K	0.13%	29

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCK Partners's LLY Position: Q2 2026 in Review

BCK Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 200 shares worth $240K. The stake represents 0.12% of the portfolio and ranks #25 among its holdings. This is a return to the name: BCK Partners previously reported a position in LLY as recently as Q4 2025.

BCK Partners first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. The position peaked at $257K in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

BCK Partners held 200 shares of Eli Lilly worth $240K as of Q2 2026.
Eli Lilly was a new BCK Partners position in Q2 2026.
Eli Lilly made up 0.12% of BCK Partners's portfolio in Q2 2026, its #25 holding.
BCK Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
BCK Partners's Eli Lilly position peaked at $257K in Q2 2024.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BCK Partners's 13F filing for Q2 2026, filed 20 Jul 2026.